MIRA
INFORM REPORT
|
Report Date : |
24.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
PRECISE CHEMIPHARMA PRIVATE LIMITED |
|
|
|
|
Registered Office : |
"Malwa" Unit No. 108, E. S. Patanwala Industrial Estate, L. B.
S. Marg, Ghatkopar (W), Mumbai – 400086, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
09.11.1993 |
|
|
|
|
Com. Reg. No.: |
11-75033 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24110MH1993PTC075033 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMP14357A |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACP3180F |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers and Exporters of Bulk Drugs and Pharmaceutical Item. |
RATING &
COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and reputed company having fine track.
Directors are reported as experienced and respectable businessmen. Trade
relations are fair. Business is active. Payments are usually correct and as
per commitments. The company can be considered good for normal business dealings. |
LOCATIONS
|
Registered Office : |
"Malwa" Unit No. 108, E. S. Patanwala Industrial Estate, L. B.
S. Marg, Ghatkopar (W), Mumbai - 400086, Maharashtra, India |
|
Tel. No.: |
91-22-25006300 / 25002131/ 65222145 / 25000517 |
|
Mobile : |
91-9820641112 |
|
Fax No.: |
91-22-25000416 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
772 sq. ft. |
|
Location : |
Rented |
|
|
|
|
Factory 1 : |
C-384, T.T.C Industrial Area, Village Pawne, Navi Mumbai – 400703, Maharashtra,
India |
|
Tel No.: |
91-22-65251416 |
|
Fax No.: |
91-22-27617550 |
|
Area : |
1000 sq. mt. |
|
Location : |
Rented |
|
|
|
|
Factory 2 : |
C-409, T.T.C Industrial Area, Opposite Mack Springs, Belapur Road, Turbhe,
Navi, Mumbai – 400703, Maharashtra, India |
|
Tel No.: |
91-22-27635662 |
|
Area : |
600 sq. mt |
|
Location : |
Rented |
DIRECTORS
|
Name : |
Mr. Pravin Virajlal Shah |
|
Designation : |
Director |
|
Address : |
102, Neelkanth Niketan, Kirani Lane, Ghatkopar [West], Mumbai –
400086, Maharashtra, India |
|
Date of Birth/Age : |
19.01.1949 |
|
Date of Appointment : |
14.10.1993 |
|
Qualifications : |
F. Y. B.Com |
|
Experience : |
30 years |
|
PAN No.: |
AAFPS8644O |
|
|
|
|
Name : |
Mr. Ila Pravin Shah |
|
Designation : |
Director |
|
Address : |
102, Neelkanth Niketan, Kirani Lane, Ghatkopar [West], Mumbai –
400086, Maharashtra, India |
|
Date of Birth/Age : |
24.10.1953 |
|
Date of Appointment : |
21.04.2001 |
|
PAN No.: |
AACPS0807P |
|
|
|
|
Name : |
Mr. Mehul Pravin Shah |
|
Designation : |
Director |
|
Address : |
102, Neelkanth Niketan, Kirani Lane, Ghatkopar [West], Mumbai –
400086, Maharashtra, India |
|
Date of Birth/Age : |
29.07.1976 |
|
Date of Appointment : |
26.09.1994 |
|
Qualifications : |
B. Sc. |
|
Experience : |
9 years |
|
PAN No.: |
AACPS0989A |
|
|
|
|
Name : |
Mr. Pranay Pravin Shah |
|
Designation : |
Director |
|
Address : |
102, Neelkanth Niketan, Kirani Lane, Ghatkopar [West], Mumbai –
400086, Maharashtra, India |
|
Date of Birth/Age : |
03.07.1979 |
|
Date of Appointment : |
02.04.1997 |
|
Qualifications : |
B. Com |
|
Experience : |
7 years |
|
PAN No.: |
ACWPS2353J |
|
|
|
|
Name : |
Mr. Sunil S. Sukthankar |
|
Designation : |
Director |
|
Address : |
Samarth Krupa, 1st Floor, behind Plaza Cinema, Dadar,
Mumbai – 400028, Maharashtra, India |
|
Date of Birth/Age : |
12.06.1961 |
|
Date of Appointment : |
01.04.2000 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
|
Names of Shareholders |
|
No. of Shares |
|
|
|
|
|
Mr. Pravin Virajlal Shah |
|
400080 |
|
Mr. Ila Pravin Shah |
|
400080 |
|
Mr. Mehul Pravin Shah |
|
400080 |
|
Mr. Pranay Pravin Shah |
|
400080 |
|
Mr. Sunil S. Sukthankar |
|
400028 |
|
|
|
|
BUSINESS DETAILS
|
Line of Business : |
Manufacturers and Exporters of Bulk Drugs and Pharmaceutical Item |
|
|
|
|
Products : |
|
|
|
|
|
Exports : |
|
|
Products : |
All Products |
|
Countries : |
|
|
|
|
|
Imports : |
|
|
Products : |
Pharmaceuticals Intermediates |
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
LC/, Credit – (45-120 days) |
|
|
|
|
Purchasing : |
L/C, Credit – (60-90 days) |
GENERAL
INFORMATION
|
Customers : |
End Users
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
58 (Office – 12
and Factory – 46) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
1, Raman Smruti, Karani
Road, Near Telephone Exchange, Ghatkoper [West], Mumbai – 400086,
Maharashtra, India
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
N. V. Joshi and Company Chartered Accountants |
|
Address : |
110, Sujata Chambars, Masjid Bunder, Mumbai, Maharashtra, India |
|
Tel No.: |
91-22-65715680/ 23432554 |
|
|
|
|
Associates/
Subsidiary : |
Mehul Trading
Company Masjid Bunder, Mumbai – 400009, Maharashtra, India (Trading of Pharmaceuticals) Corporation Bank Precise
Biopharma Private Limited 209, Jhalawar, Ghatkopar (West), Mumbai – 400086, Maharashtra, India (Exporter of Formulations) Corporation Bank |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5000 |
Equity Shares |
Rs.100/- each |
Rs.0.500 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5000 |
Equity Shares |
Rs.100/- each |
Rs.0.500 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.500 |
0.209 |
0.209 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
37.786 |
26.713 |
20.738 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
38.286 |
26.922 |
20.947 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
24.287 |
9.556 |
5.529 |
|
|
2] Unsecured Loans |
11.553 |
7.134 |
6.657 |
|
|
TOTAL BORROWING |
35.840 |
16.690 |
12.186 |
|
|
DEFERRED TAX LIABILITIES |
0.941 |
0.646 |
0.703 |
|
|
|
|
|
|
|
|
TOTAL |
75.067 |
44.258 |
33.836 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
18.385 |
15.833 |
13.754 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
24.963
|
24.482
|
15.976
|
|
|
Sundry Debtors |
43.353
|
17.542
|
15.473
|
|
|
Cash & Bank Balances |
0.788
|
1.690
|
[2.188]
|
|
|
Other Current Assets |
0.000
|
0.000
|
6.754
|
|
|
Loans & Advances |
16.021
|
8.330
|
6.460
|
|
Total
Current Assets |
85.125
|
52.044 |
42.475
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
16.496
|
17.036
|
22.393 |
|
|
Provisions |
11.947
|
6.583
|
0.000 |
|
Total
Current Liabilities |
28.443
|
23.619 |
22.393
|
|
|
Net Current Assets |
56.682
|
28.425 |
20.082
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
75.067 |
44.258 |
33.836 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
Sales Turnover |
166.681 |
101.426 |
80.309 |
|
Other Income |
0.000 |
0.000 |
0.000 |
|
Total Income |
166.681 |
101.426 |
80.309 |
|
|
|
|
|
|
Profit/(Loss) Before Tax |
17.873 |
9.010 |
3.640 |
|
Provision for Taxation |
6.506 |
3.093 |
1.122 |
|
Profit/(Loss) After Tax |
11.367 |
5.917 |
2.518 |
|
|
|
|
|
|
Expenditures : |
|
|
|
|
Cost of Goods
Sold |
24.482 |
15.977 |
|
|
Purchases |
104.856 |
61.446 |
|
|
Manufacturing
Expenses |
13.861 |
10.391 |
76.669 |
|
Direct Expenses |
5.609 |
4.602 |
|
|
Other Expenses |
0.000 |
0.000 |
|
|
Total Expenditure |
148.808 |
92.416 |
76.669 |
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
6.82
|
5.83 |
3.14
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
10.72
|
8.88 |
4.53
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
17.27
|
13.27 |
6.47
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.47
|
0.33 |
0.17
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
64.28
|
26.92 |
1.65
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.99
|
2.20 |
1.90
|
LOCAL AGENCY
FURTHER INFORMATION
INSURANCE
DETAILS (Rs. In Millions)
|
Unit’s Assets Covered |
Policy No./ Cover Note |
Validity |
Sum Assured |
|
|
|
|
|
|
C – 384 |
PSP00050987000-00 |
7-7-2009 |
23.000 |
|
C – 409 |
120400/11/7/11/1124 |
4-11-2008 |
8.500 |
|
Twenty First |
120400/11/1/1111600 |
15-2-2009 |
1.800 |
FINANCIAL
ANALYSIS (RS. IN MILLIONS)
|
Last available financial Statement (Year ended dd/mm/yy) |
31.03.2007 |
||||||||||
|
Recent Summary Financials (upto a period not more than two months old)
|
30.06.2008 |
||||||||||
|
Advance Taxes Paid |
15.06.2008
(1.750) |
||||||||||
|
Change in borrowings (From FY-FY) |
|
||||||||||
|
Debtors Positions (At last months end-specify amount 90 days) |
30.06.2008
(64.727) |
||||||||||
|
Credit Positions (At last months end-specify all suppliers not paid
for more than 90 days) |
30.06.2008
(12.924) |
||||||||||
|
Stock Position (at last month end) |
30.06.2008
(.31.341) |
||||||||||
|
Drawing Power |
(16.575) |
||||||||||
|
Any other materials development |
|
||||||||||
|
Whether the critical rations conforms to the bench mark stipulation |
|
OTHER
PARTICULARS
(Rs. In Millions)
|
Months
(During the current year) |
Purchases |
Sales |
|
|
|
|
|
April – 08 |
12.929 |
20.042 |
|
May – 08 |
9.746 |
17.309 |
|
June – 08 |
16.620 |
21.745 |
|
Document Verified |
|
|
STATEMENT OF
ASSETS AND LIABILITY
(MR. PRAVIN
SHAH)
INVESTMENT
IN BUSINESS CAPITAL
|
Name of the
Company/ Firm/ Concern in which investment is made |
Rs.
In Millions |
|
|
|
|
Precise Chemipharma Private Limited |
3.562 |
|
Precise Bio Pharma Private Limited |
0.557 |
|
Mehul Trading Company |
0.266 |
|
Pranay P. Shah |
0.302 |
|
P. V. Shah Chufi |
0.622 |
|
Ila P. Shah |
0.746 |
DEPOSITS
HELD WITH BANKS
|
Name
of the Bank |
Nature of Deposits Held |
Rs. In Millions |
|
|
|
|
|
Corporation Bank |
S. B. A/C |
0.213 |
DEPOSITS
HELD WITH COMPANIES/ OTHERS
|
Name
of the Bank |
Nature of Deposits |
Rs. In Millions |
|
|
|
|
|
Shreya Developer |
Deposit |
0.350 |
|
Bhoome Construction |
Deposit |
0.350 |
IMMOVABLE
PROPERTIES
|
Name
of the Owner |
Description of Property |
Location/ Address of the Property |
Details of Documents Conferring Right |
Original Purchases Cost (Millions) |
|
|
|
|
|
|
|
Neelkanth Flat No.102 |
Flat |
Ghatkopar (West) |
Owner Ship |
0.489 |
|
Sujata Chambers |
Office |
Masjid Bunder |
Owner Ship |
0.045 |
|
Mithila |
Flat |
Vidhya Vihar |
Owner Ship |
1.525 |
Government
Security/ National Savings Certificates/ Shares of listed companies/ Units of
Unit Trust of India
|
Description of
Security |
Face Value (Millions) |
|
|
|
|
Shares and Debentures |
0.040 |
|
PPF |
1.458 |
Including
Movable Assets like furniture and Fixture/ Plant and Machinery/ Vehicles/
Jewels etc.
|
Description
of Security |
Face Value (Millions) |
|
|
|
|
Gold and Jeweller |
0.173 |
|
Cash |
0.008 |
Total Assets:
Rs.10.709 Millions
FACILITIES
WITH FINANCIAL INSTITUTE AND BANK:
|
Name of the
Institution/ Bank |
Nature of Credit Facility |
Extent (Rs. In Millions) |
|
|
|
|
|
Corporation Bank |
Housing Loan |
0.717 |
BORROWINGS
FROM OTHERS:
|
Name of the
Lender |
Amount Borrowed (Millions) |
|
|
|
|
All Season Dry Fruits |
0.785 |
Total Liability:
Rs.1.502 Millions
Total Net Worth:
Rs.9.207 Millions
Capital
Personal Account
(Mr.
Pravin V. Shah)
|
Particulars |
Rs. In Millions |
Particulars |
Rs. In Millions |
|
|
|
|
|
|
To Drawings |
0.216 |
By Balance b/d |
6.980 |
|
To LTC |
0.088 |
By Agriculture Income |
0.060 |
|
To TDS |
0.464 |
By LTC Refund |
0.165 |
|
To Medicalim |
0.008 |
By Dividend |
0.023 |
|
To Housing Interests |
0.028 |
By Bank Interests |
0.004 |
|
To TDS |
0.007 |
By Interests From Mehul Trading Company |
0.068 |
|
To Advance Tax |
0.550 |
By PPF Interests |
0.103 |
|
To Professional Tax |
0.003 |
By Profit From Mehul Trading Company |
1.057 |
|
To Balance c/d |
9.207 |
By Interests Recd From Precise Chemi Pharma |
0.150 |
|
|
|
By Share Profi |
0.460 |
|
|
|
By Remuneration |
1.500 |
|
|
|
|
|
|
Total |
10.571 |
Total |
10.571 |
BALANCE
SHEET
|
Particulars |
Rs. In Millions |
Particulars |
Rs. In Millions |
|
|
|
|
|
|
Capital Account |
|
Fixed Assets |
|
|
|
|
|
|
|
Capital A/C |
9.207 |
Neelkanth Flat No.102 |
0.489 |
|
Housing Loans |
0.717 |
Sujata Chambers Office |
0.045 |
|
All Season dry Fruits |
0.785 |
Shares and Debenture |
0.040 |
|
|
|
Precise Chemi Pharma Share |
3.312 |
|
|
|
Precise Bio Pharma |
0.557 |
|
|
|
Precise Chemi Pharma |
0.250 |
|
|
|
Pranay Pravin Shah |
0.303 |
|
|
|
Mehul Trading Company |
0.266 |
|
|
|
Mithila |
1.525 |
|
|
|
Pravin V. Shah HUF |
0.622 |
|
|
|
IIa P. Shah |
0.746 |
|
|
|
Shreya Developers |
0.350 |
|
|
|
Gold and Jewellery |
0.173 |
|
|
|
Bhoomi Construction |
0.352 |
|
|
|
PPF |
1.458 |
|
|
|
Corporation Bank |
0.213 |
|
|
|
Cash on Hand |
0.008 |
|
|
|
|
|
|
Total |
10.709 |
Total |
10.709 |
STATEMENT OF
ASSETS AND LIABILITY
(MR. MEHUL
SHAH)
INVESTMENT
IN BUSINESS CAPITAL
|
Name of the
Company/ Firm/ Concern in which investment is made |
Rs.
In Millions |
|
|
|
|
Precise Chemipharma Private Limited |
3.546 |
|
Precise Bio Pharma Private Limited |
0.650 |
|
Global Link Inc. |
0.701 |
DEPOSITS
HELD WITH BANKS
|
Name
of the Bank |
Nature of Deposits Held |
Rs. In Millions |
|
|
|
|
|
ABN Amro Bank |
- |
0.051 |
|
Corporation Bank |
SB. A/C |
0.247 |
IMMOVABLE
PROPERTIES
|
Name
of the Owner |
Description of Property |
Location/ Address of the Property |
Details of Documents Conferring Right |
Original Purchases Cost (Millions) |
|
|
|
|
|
|
|
Jhalawar Office |
Office |
Ghatkopar (West) |
Owner Ship |
0.381 |
|
Tul |
Flat |
Ghatkopar (West) |
Owner Ship |
1.670 |
Government
Security/ National Savings Certificates/ Shares of listed companies/ Units of
Unit Trust of India
|
Description of
Security |
Face Value (Millions) |
|
|
|
|
Shares and Debentures |
0.006 |
|
PPF |
1.351 |
Including
Movable Assets like furniture and Fixture/ Plant and Machinery/ Vehicles/
Jewels etc.
|
Description
of Security |
Face Value (Millions) |
|
|
|
|
Gold and Jeweller |
0.026 |
|
Cash |
0.001 |
Total Assets:
Rs.8.630 Millions
FACILITIES
WITH FINANCIAL INSTITUTE AND BANK
|
Name of the
Institution/ Bank |
Nature of Credit Facility |
Extent (Rs. In Millions) |
|
|
|
|
|
Corporation Bank |
Housing Loan |
0.601 |
BORROWINGS
FROM OTHERS
|
Name of the
Lender |
Amount Borrowed (Millions) |
|
|
|
|
R. M. Shah |
0.550 |
|
Ila P. Shah |
0.006 |
Total Liability:
Rs.1.157 Millions
Total Net Worth:
Rs.7.473 Millions
Capital
Personal Account
(Mr.
Mehul Shah)
|
Particulars |
Rs. In Millions |
Particulars |
Rs. In Millions |
|
|
|
|
|
|
To LTC |
0.149 |
By Balance b/d |
3.445 |
|
To Mediclaim |
0.009 |
By Dividend |
0.016 |
|
To TDS |
0.473 |
By Bank Interests |
0.004 |
|
To Drawings |
0.312 |
By FDR Interests |
0.009 |
|
To FDR TDS |
0.001 |
By PPF Interest |
0.095 |
|
To Advance Tax |
0.125 |
By Directors Remunaration |
1.500 |
|
To Professional Tax |
0.003 |
By Short Term Profit |
2.710 |
|
To Harsmis Interests |
0.024 |
By LIC Refund |
0.060 |
|
To Balance c/d |
7.473 |
By Rent Road From Precise Chemi Pharma |
0.132 |
|
|
|
By MTNL Deposit |
0.001 |
|
|
|
By Hutch deposit |
0.003 |
|
|
|
By Income Tax Refund |
0.036 |
|
|
|
By Interests From Precise Chemi Pharma |
0.044 |
|
|
|
By Profit From Global Link Inc. |
0.514 |
|
|
|
|
|
|
Total |
8.569 |
Total |
8569 |
BALANCE
SHEET
|
Particulars |
Rs. In Millions |
Particulars |
Rs. In Millions |
|
|
|
|
|
|
Capital Account |
|
Fixed Assets |
|
|
|
|
|
|
|
Mehul P. Shah |
7.473 |
Jhalawar Office |
0.381 |
|
Ruchana |
0.550 |
Precise Chemi Pharma Share |
3.452 |
|
Tukhshilu Bank Loan |
0.601 |
Precise Bio Pharma |
0.650 |
|
IIa P. Shah |
0.006 |
Global Link |
0.701 |
|
|
|
PPF |
1.351 |
|
|
|
Shares and Debenture |
0.006 |
|
|
|
Tuksha Shila |
1.671 |
|
|
|
ABN Amro Bank |
0.051 |
|
|
|
Precise Chemi Pharma SH |
0.095 |
|
|
|
Gold and Jewellery |
0.026 |
|
|
|
Corporation Bank |
0.245 |
|
|
|
Cash |
0.001 |
|
|
|
|
|
|
Total |
8.630 |
Total |
8.630 |
Trade Reference:
- Kanchan
Rasayan
Rajasthan Technical
Centre, 1st Floor,
Patanwala Estate, LBS Marg, Ghatkopar (West), Mumbai – 400086, Maharashtra,
India
Mr. Hitesh J. Shah
Tel No.: 91-22-66312397
- Thykn (India)
International
202, Kuntal, Mody Estate,
LBS Marg, Ghatkopar (West), Mumbai – 400086, Maharashtra, India
Mr. Hirenbhai
Tel No.: 91-22-67033666
- Hemlin
Chemicals
108, Jhalawar, 1st Floor, Patanwala Estate, LBS Marg, Ghatkopar (West), Mumbai – 400086, Maharashtra, India
Mr. Kamlesh Shah
Tel No.: 91-22-25001179
Bankers Charges
Report as per Registry
|
Name of the
company |
PRECISE CHEMIPHARMA PRIVATE LIMITED |
|
Presented By |
K. Gopalkrishna Bhat, Chief Manager. Corporation Bank, Ghatkoper
[West], Mumbai – 400086, Maharashtra, India |
|
1) Date and description of instrument creating the change |
Hypothecation
Deed of Export Credit Agreement Deed Both Dated 09.03.2002 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs. 5.000
Millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Hypothecation of stocks
of raw materials, work in progress and finished goods of drugs and
pharmaceuticals Supply Bills,
Cheques and bills of exchange accepted or endorsed by the borrower |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
|
|
5) Name and Address and description of the person entitled to the charge. |
Corporation Bank 1, Raman Smruti,
Karani Road, Near Telephone
Exchange, Ghatkoper [West],
Mumbai – 400086 |
|
6) Date and brief description of instrument modifying the charge |
Common deed of
hypothecation Deed and Export credit agreement deed both dated 09.03.2002 was
registered at ROC on 02.05.2002 at Sr. No. 23 and first modification for
total Rs.14.000 Millions was registered at ROC on 29.03.2004 at Sr No. 38 |
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
This common deed
of hypothecation of movables / assets / debts dated 09.09.2005 is 2nd
modification for Rs.20.500 Millions as per various credit facilities as
mentioned in the said deed on Hypothecation of stock in trade, book debts
consisting of Goods, drugs and pharmaceuticals stored / kept in factory
premises. |
Fixed Assets
- Air Condition
- Computer
- Furniture and
Fitting
- Land
- Motor Car
- Plant and
Machinery
- Weghing Scale
- Weghing BAL
AS PER WEBSITE
ORGANIZATION
Subject
incorporated in the year 1994, with aim of catering the need of the Domestic
& international markets for Active Pharmaceutical Ingredients.
Subject
is an Indian enterprise molded by global aspirations. This has always demanded
a preparedness and long- term organizational vision that can encompass the
turbulences and paradoxes of shifting terms and terrain's of business
In the
emerging industry patterns of the twenty-first century, based on new
technologies, innovative product development has to be complemented with
cost effective therapeutic solutions to address a better informed and a more
demanding fraternity. To achieve this, Subject has harnessed all its strengths
- compact productive teams, modern facilities.
Subject
has achieved command over chemical technologies and economies of scale - into a
synergistic organic entity, continuously creating and nurturing high quality
products and technologies. Their emphasis is on Designing the eco-friendly
process by considering the Environmental issues, setting objectives and Targets
towards conservation of the Natural resources.
THE EXTENSIVE RANGE OF REACTIONS CARRIED OUT AT PRECISE
- Acylation
- Nitration
- Amoxidation
- Alkylation
- Oxidation
- Cyanation
- Amination
- Optical
Resolution
- Hydroboration
- Bromination
- Reaction In
Liquid
Ammonia
- Formylation
- Hydrogenation
- Grignard
Reactions
- Reductive
Amination
- Diazotization
- Reduction
- Sandmeye
- Reaction
CREATIVITY AND SERVICES
QUALITY ASSURANCE AT
PRECISE
They place a heavy emphasis on
quality standards using customer needs as a benchmark. For each drug substance,
impurities and degradation products, exceeding 0.1% are identified and
characterized.
AIMING TOWARDS
PERFECTION
Each operational division at
Precise aims to achieve the consistent result every time by following the
validated methods; every step of production process is carefully monitored and
controlled. From the Raw-material to the finished product stage, a quality
verification system performs inspections of products, thanks to the
sophisticated instrumentations like Hplc, G.C, U.V, Digital Polarimeter, Auto
Titrator, Digital Melting Point Apparatus etc and trained personnel.
EUROPEAN DRUG MASTER
FILES
They have already prepared E-DMF
of Zolpidem Hemi-tartarate, Alendronare Sodium and few others are under process.
This is their effort to show their commitment towards quality. Some of the
E-DMF’S in the pipeline are of Midazolam, Sodium Picosulphate, Itopride
Hydrochloride and Fenoxazoline Hydrochloride.
NEW HORIZONS
After successfully proving it’s ability in the manufacture of Active
Pharmaceutical Ingredients, Precise has expanded it’s horizon by entering in to
the manufacture of solid dosage forms of API.Precise has stared the manufacture
of drug pellets. The enteric coated drug pellets such as Omeprazole,
Lansoprazole and Pantoprazole Sodium and Rabeprazole sodium are manufactured
with the state of the art technology to cater the need of the pharmaceutical
industry.
They also manufacture other drug pellets of delayed release such as
Diclofenac Sodium, Itopride hydrochloride and Ibuprofen and few other are in
the pipeline.
The pelletization plant is equipped with various types of drug and
polymer coating machines for commercial as well as pilot scale. The plant is
designed to comply GMP standards and soon the GMP Certification also will be
applied.
To support the quality parameters of the pellets, they are equipped with
the relevant sophisticated
Instrumentation such as HPLC, Dissolution apparatus, Pellet size
analyzer and a well equipped microbiological Laboratory.
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.33 |
|
UK Pound |
1 |
Rs.84.32 |
|
Euro |
1 |
Rs.66.75 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
61 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|